ASHLEY WATSON: Open Payments
NPI 1427454826 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 36 payments from 10 companies in 2025. Trend: 2023 $605 · 2024 $580 · 2025 $525
Food & beverage: $406Education: $119
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $167 |
| Regeneron Healthcare Solutions, Inc. | 5 | $142 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Insmed, Inc. | 2 | $35 |
| HARMONY BIOSCIENCES LLC | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Viatris Specialty LLC | 1 | $23 |
| Pulmonx Corporation | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| United Therapeutics Corporation | 1 | $16 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, FASENRA, WAKIX, INGREZZA, YUPELRI, CHARTIS CATHETER.
Industry payments across OH — which companies pay providers there.
